David W. Dawson
8Patents
5h-index
7Co-inventors
48Inventor score
Filing activity: Mar 16, 1998 → Jul 26, 2006
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5932545A | Antiangiogenic drug to treat cancer, arthritis and retinopathy | Emerging Cross-Sectional Technologies | 48 | Expired |
| US6288024A | Methods and compositions for inhibiting angiogenesis | Chemistry; Metallurgy | 11 | Expired |
| US6797691B1 | Methods and compositions for inhibiting angiogenesis | Human Necessities | 10 | Expired |
| US6670333B2 | Methods and compositions for inhibiting angiogenesis | Chemistry; Metallurgy | 7 | Expired |
| US6391850B2 | Methods and compositions for inhibiting angiogenesis | Chemistry; Metallurgy | 7 | Expired |
| US6919309B2 | Methods and compositions for inhibiting angiogenesis | Human Necessities | 3 | Expired |
| US7105496B2 | Methods and compositions for inhibiting angiogenesis | Physics | 3 | Expired |
| US7723313B2 | Methods and compositions for inhibiting angiogenesis | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.